☰

Jiangtao Li, Ph.D. - Publications

Affiliations: 
2006 Purdue University, West Lafayette, IN, United States 
Area:
Computer Science
Tree Info Similar researchers PubMed Report error

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Wang S, Zhang Y, Wang Y, Ye P, Li J, Li H, Ding Q, Xia J. Amphiregulin Confers Regulatory T Cell Suppressive Function and Tumor Invasion via the EGFR/GSK-3β/Foxp3 Axis. The Journal of Biological Chemistry. PMID 27432879 DOI: 10.1074/jbc.M116.717892  0.309
2016 Tong M, Zheng W, Li H, Li X, Ao L, Shen Y, Liang Q, Li J, Hong G, Yan H, Cai H, Li M, Guan Q, Guo Z. Multi-omics landscapes of colorectal cancer subtypes discriminated by an individualized prognostic signature for 5-fluorouracil-based chemotherapy. Oncogenesis. 5: e242. PMID 27429074 DOI: 10.1038/oncsis.2016.51  0.319
2016 Ge Z, Gu Y, Zhao G, Li J, Chen B, Han Q, Guo X, Liu J, Li H, Yu MD, Olson J, Steffens S, Payne KJ, Song C, Dovat S. High CRLF2 expression associates with IKZF1 dysfunction in adult acute lymphoblastic leukemia without CRLF2 rearrangement. Oncotarget. PMID 27391346 DOI: 10.18632/oncotarget.10437  0.312
2016 Chen S, Chen X, Xie G, He Y, Yan D, Zheng D, Li S, Fu X, Li Y, Pang X, Hu Z, Li H, Tan W, Li J. Cdc6 contributes to cisplatin-resistance by activation of ATR-Chk1 pathway in bladder cancer cells. Oncotarget. PMID 27246979 DOI: 10.18632/oncotarget.9616  0.309
2016 Ao L, Song X, Li X, Tong M, Guo Y, Li J, Li H, Cai H, Li M, Guan Q, Yan H, Guo Z. An individualized prognostic signature and multi‑omics distinction for early stage hepatocellular carcinoma patients with surgical resection. Oncotarget. PMID 27006471 DOI: 10.18632/oncotarget.8212  0.31
2016 Ren D, Li H, Li R, Sun J, Guo P, Han H, Yang Y, Li J. Novel insight into MALAT-1 in cancer: Therapeutic targets and clinical applications. Oncology Letters. 11: 1621-1630. PMID 26998053 DOI: 10.3892/ol.2016.4138  0.319
2016 Geng P, Sa R, Li J, Li H, Liu C, Liao Y, Xiang L, Wang N, Ou J, Xie G, Liang H. Genetic polymorphisms in C-reactive protein increase cancer susceptibility. Scientific Reports. 6: 17161. PMID 26912098 DOI: 10.1038/srep17161  0.302
2016 Gao X, Fan L, Li H, Li J, Liu X, Sun R, Yu Z. Hepatic injury is associated with cell cycle arrest and apoptosis with alteration of cyclin A and D1 in ammonium chloride-induced hyperammonemic rats. Experimental and Therapeutic Medicine. 11: 427-434. PMID 26893626 DOI: 10.3892/etm.2015.2931  0.3
2016 Li X, Cai H, Zheng W, Tong M, Li H, Ao L, Li J, Hong G, Li M, Guan Q, Yang S, Yang D, Lin X, Guo Z. An individualized prognostic signature for gastric cancer patients treated with 5-Fluorouracil-based chemotherapy and distinct multi-omics characteristics of prognostic groups. Oncotarget. PMID 26840027 DOI: 10.18632/oncotarget.7087  0.308
2016 Li J, Huang KL, Zhang T, Li H, Zhao J, Wang H. Pan-cancer methylation and expression profiling of adenocarcinomas revealed epigenetic silencing in the WNT signaling pathway. Neoplasma. PMID 26774141 DOI: 10.4149/205_150601N306  0.304
2016 Liu F, Tong D, Li H, Liu M, Li J, Wang Z, Cheng X. Bufalin enhances antitumor effect of paclitaxel on cervical tumorigenesis via inhibiting the integrin α2/β5/FAK signaling pathway. Oncotarget. PMID 26758421 DOI: 10.18632/oncotarget.6840  0.31
Show low-probability matches.